These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18255197

  • 1. QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
    Lü WJ, Chen YL, Ma WP, Zhang XY, Luan F, Liu MC, Chen XG, Hu ZD.
    Eur J Med Chem; 2008 Mar; 43(3):569-76. PubMed ID: 18255197
    [Abstract] [Full Text] [Related]

  • 2. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S.
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [Abstract] [Full Text] [Related]

  • 3. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
    Mercader AG, Pomilio AB.
    Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
    [Abstract] [Full Text] [Related]

  • 4. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
    Xia B, Ma W, Zheng B, Zhang X, Fan B.
    Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
    [Abstract] [Full Text] [Related]

  • 5. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
    Li ZS, Sun JY, Liang GZ, Lu FL, Zhu WP, Zhang MJ, Zhang Y, Yang SB, Shu M, Chen GH, Lu TT.
    Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
    [Abstract] [Full Text] [Related]

  • 6. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J, Cai S, Mei H, Li J, Yan N, Wang Q, Lin Z, Huo D.
    Chem Biol Drug Des; 2010 Sep 01; 76(3):245-54. PubMed ID: 20626407
    [Abstract] [Full Text] [Related]

  • 7. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
    Gao L, Zu M, Wu S, Liu AL, Du GH.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5964-70. PubMed ID: 21843936
    [Abstract] [Full Text] [Related]

  • 8. Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J, Pan X, Wang C, Wang F, Li P, Xu W, He L.
    Chem Biol Drug Des; 2012 Mar 01; 79(3):353-9. PubMed ID: 22222003
    [Abstract] [Full Text] [Related]

  • 9. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
    Nair PC, Sobhia ME.
    Eur J Med Chem; 2008 Feb 01; 43(2):293-9. PubMed ID: 17513019
    [Abstract] [Full Text] [Related]

  • 10. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS, Huang RB, Wei YT, Du LQ, Chou KC.
    J Comput Chem; 2008 Jan 30; 29(2):211-9. PubMed ID: 17559075
    [Abstract] [Full Text] [Related]

  • 11. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N, Senkovich O, Walker K, Wright DL, Anderson AC, Rosowsky A, Ananthan S, Shinkre B, Velu S, Chattopadhyay D.
    Proteins; 2008 Dec 30; 73(4):889-901. PubMed ID: 18536013
    [Abstract] [Full Text] [Related]

  • 12. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
    Abu Hammad AM, Afifi FU, Taha MO.
    J Mol Graph Model; 2007 Sep 30; 26(2):443-56. PubMed ID: 17360207
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM, Taha MO.
    J Chem Inf Model; 2009 Apr 30; 49(4):978-96. PubMed ID: 19341295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS, Huang RB, Wei YT, Pang ZW, Du LQ, Chou KC.
    J Comput Chem; 2009 Jan 30; 30(2):295-304. PubMed ID: 18613071
    [Abstract] [Full Text] [Related]

  • 19. Quantitative structure-lambda(max) relationship study on flavones by heuristic method and radial basis function neural network.
    Liu H, Wen Y, Luan F, Gao Y, Li X.
    Anal Chim Acta; 2009 Sep 01; 649(1):52-61. PubMed ID: 19664462
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.